Cargando…

Quality of life assessment in interstitial lung diseases:a comparison of the disease-specific K-BILD with the generic EQ-5D-5L

BACKGROUND: Patients with interstitial lung diseases (ILD) have impaired health-related quality of life (HRQL). Little is known about the applicability of the disease-specific King’s Brief Interstitial Lung Disease questionnaire (K-BILD) and the generic EQ-5D-5L in a German setting. METHODS: We asse...

Descripción completa

Detalles Bibliográficos
Autores principales: Szentes, Boglárka Lilla, Kreuter, Michael, Bahmer, Thomas, Birring, Surinder S., Claussen, Martin, Waelscher, Julia, Leidl, Reiner, Schwarzkopf, Larissa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5970441/
https://www.ncbi.nlm.nih.gov/pubmed/29801506
http://dx.doi.org/10.1186/s12931-018-0808-x
_version_ 1783326128919805952
author Szentes, Boglárka Lilla
Kreuter, Michael
Bahmer, Thomas
Birring, Surinder S.
Claussen, Martin
Waelscher, Julia
Leidl, Reiner
Schwarzkopf, Larissa
author_facet Szentes, Boglárka Lilla
Kreuter, Michael
Bahmer, Thomas
Birring, Surinder S.
Claussen, Martin
Waelscher, Julia
Leidl, Reiner
Schwarzkopf, Larissa
author_sort Szentes, Boglárka Lilla
collection PubMed
description BACKGROUND: Patients with interstitial lung diseases (ILD) have impaired health-related quality of life (HRQL). Little is known about the applicability of the disease-specific King’s Brief Interstitial Lung Disease questionnaire (K-BILD) and the generic EQ-5D-5L in a German setting. METHODS: We assessed disease-specific (K-BILD) and generic HRQL (EQ-5D experience based value set (EBVS) and Visual Analog Scale (VAS)) in 229 patients with different ILD subtypes in a longitudinal observational study (HILDA). Additionally, we assessed the correlation of the HRQL measures with lung function and comorbidities. In a linear regression model, we investigated predictors (including age, sex, ILD subtype, FVC percentage of predicted value (FVC%pred), DLCO percentage of predicted value, and comorbidities). RESULTS: Among the 229 patients mean age was 63.2 (Standard deviation (SD): 12.9), 67.3% male, 24.0% had idiopathic pulmonary fibrosis, and 22.3% sarcoidosis. Means scores were as follows for EQ-5D EBVS 0.66(SD 0.17), VAS 61.4 (SD 19.1) and K-BILD Total 53.6 (SD 13.8). K-BILD had good construct validity (high correlation with EQ-5D EBVS (0.71)) and good internal consistency (Cronbach’s alpha 0.89). Moreover, all HRQL measures were highly accepted by patients including low missing items and there were no ceiling or floor effects. A higher FVC % pred was associated with higher HRQL in all measures meanwhile comorbidities had a negative influence on HRQL. CONCLUSIONS: K-BILD and EQ-5D had similar HRQL trends and were associated similarly to the same disease-related factors in Germany. Our data supports the use of K-BILD in clinical practice in Germany, since it captures disease specific effects of ILD. Additionally, the use of the EQ-5D-5L could provide comparison to different disease areas and give an overview about the position of ILD patients in comparison to general population. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12931-018-0808-x) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5970441
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-59704412018-05-30 Quality of life assessment in interstitial lung diseases:a comparison of the disease-specific K-BILD with the generic EQ-5D-5L Szentes, Boglárka Lilla Kreuter, Michael Bahmer, Thomas Birring, Surinder S. Claussen, Martin Waelscher, Julia Leidl, Reiner Schwarzkopf, Larissa Respir Res Research BACKGROUND: Patients with interstitial lung diseases (ILD) have impaired health-related quality of life (HRQL). Little is known about the applicability of the disease-specific King’s Brief Interstitial Lung Disease questionnaire (K-BILD) and the generic EQ-5D-5L in a German setting. METHODS: We assessed disease-specific (K-BILD) and generic HRQL (EQ-5D experience based value set (EBVS) and Visual Analog Scale (VAS)) in 229 patients with different ILD subtypes in a longitudinal observational study (HILDA). Additionally, we assessed the correlation of the HRQL measures with lung function and comorbidities. In a linear regression model, we investigated predictors (including age, sex, ILD subtype, FVC percentage of predicted value (FVC%pred), DLCO percentage of predicted value, and comorbidities). RESULTS: Among the 229 patients mean age was 63.2 (Standard deviation (SD): 12.9), 67.3% male, 24.0% had idiopathic pulmonary fibrosis, and 22.3% sarcoidosis. Means scores were as follows for EQ-5D EBVS 0.66(SD 0.17), VAS 61.4 (SD 19.1) and K-BILD Total 53.6 (SD 13.8). K-BILD had good construct validity (high correlation with EQ-5D EBVS (0.71)) and good internal consistency (Cronbach’s alpha 0.89). Moreover, all HRQL measures were highly accepted by patients including low missing items and there were no ceiling or floor effects. A higher FVC % pred was associated with higher HRQL in all measures meanwhile comorbidities had a negative influence on HRQL. CONCLUSIONS: K-BILD and EQ-5D had similar HRQL trends and were associated similarly to the same disease-related factors in Germany. Our data supports the use of K-BILD in clinical practice in Germany, since it captures disease specific effects of ILD. Additionally, the use of the EQ-5D-5L could provide comparison to different disease areas and give an overview about the position of ILD patients in comparison to general population. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12931-018-0808-x) contains supplementary material, which is available to authorized users. BioMed Central 2018-05-25 2018 /pmc/articles/PMC5970441/ /pubmed/29801506 http://dx.doi.org/10.1186/s12931-018-0808-x Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Szentes, Boglárka Lilla
Kreuter, Michael
Bahmer, Thomas
Birring, Surinder S.
Claussen, Martin
Waelscher, Julia
Leidl, Reiner
Schwarzkopf, Larissa
Quality of life assessment in interstitial lung diseases:a comparison of the disease-specific K-BILD with the generic EQ-5D-5L
title Quality of life assessment in interstitial lung diseases:a comparison of the disease-specific K-BILD with the generic EQ-5D-5L
title_full Quality of life assessment in interstitial lung diseases:a comparison of the disease-specific K-BILD with the generic EQ-5D-5L
title_fullStr Quality of life assessment in interstitial lung diseases:a comparison of the disease-specific K-BILD with the generic EQ-5D-5L
title_full_unstemmed Quality of life assessment in interstitial lung diseases:a comparison of the disease-specific K-BILD with the generic EQ-5D-5L
title_short Quality of life assessment in interstitial lung diseases:a comparison of the disease-specific K-BILD with the generic EQ-5D-5L
title_sort quality of life assessment in interstitial lung diseases:a comparison of the disease-specific k-bild with the generic eq-5d-5l
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5970441/
https://www.ncbi.nlm.nih.gov/pubmed/29801506
http://dx.doi.org/10.1186/s12931-018-0808-x
work_keys_str_mv AT szentesboglarkalilla qualityoflifeassessmentininterstitiallungdiseasesacomparisonofthediseasespecifickbildwiththegenericeq5d5l
AT kreutermichael qualityoflifeassessmentininterstitiallungdiseasesacomparisonofthediseasespecifickbildwiththegenericeq5d5l
AT bahmerthomas qualityoflifeassessmentininterstitiallungdiseasesacomparisonofthediseasespecifickbildwiththegenericeq5d5l
AT birringsurinders qualityoflifeassessmentininterstitiallungdiseasesacomparisonofthediseasespecifickbildwiththegenericeq5d5l
AT claussenmartin qualityoflifeassessmentininterstitiallungdiseasesacomparisonofthediseasespecifickbildwiththegenericeq5d5l
AT waelscherjulia qualityoflifeassessmentininterstitiallungdiseasesacomparisonofthediseasespecifickbildwiththegenericeq5d5l
AT leidlreiner qualityoflifeassessmentininterstitiallungdiseasesacomparisonofthediseasespecifickbildwiththegenericeq5d5l
AT schwarzkopflarissa qualityoflifeassessmentininterstitiallungdiseasesacomparisonofthediseasespecifickbildwiththegenericeq5d5l